Published in Arch Neurol on September 01, 1993
A review of MRI findings in schizophrenia. Schizophr Res (2001) 8.95
Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging. Neurobiol Aging (2006) 3.26
Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry (1996) 2.70
Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI. Neuroimage (2008) 2.36
Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain (2009) 2.05
Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers. PLoS One (2012) 1.64
Memory, language, and ageing. Philos Trans R Soc Lond B Biol Sci (1997) 1.33
Aging, gender, and the elderly adult brain: an examination of analytical strategies. Neurobiol Aging (2006) 1.30
Age effects on hippocampal structural changes in old men: the HAAS. Neuroimage (2007) 1.09
Hippocampal volume and shape analysis in an older adult population. Clin Neuropsychol (2007) 1.08
Memory after silent stroke: hippocampus and infarcts both matter. Neurology (2012) 1.05
A review of the brain structure correlates of successful cognitive aging. J Neuropsychiatry Clin Neurosci (2011) 1.02
Medial temporal lobe atrophy in stroke patients: relation to pre-existing dementia. J Neurol Neurosurg Psychiatry (1998) 0.99
Aerobic exercise increases hippocampal volume in older women with probable mild cognitive impairment: a 6-month randomised controlled trial. Br J Sports Med (2014) 0.99
Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders. Neurobiol Aging (2010) 0.98
Inter-racial, gender and aging influences in the length of anterior commissure-posterior commissure line. J Korean Neurosurg Soc (2008) 0.94
Impact of age-related neuroglial cell responses on hippocampal deterioration. Front Aging Neurosci (2015) 0.88
Memory encoding and dopamine in the aging brain: a psychopharmacological neuroimaging study. Cereb Cortex (2009) 0.88
An evaluation of distinct volumetric and functional MRI contributions toward understanding age and task performance: a study in the basal ganglia. Brain Res (2007) 0.88
The effects of aging in delay and trace human eyeblink conditioning. Psychol Aging (2010) 0.86
Medial temporal lobe volume predicts elders' everyday memory. Psychol Sci (2013) 0.86
Mild cognitive impairment: historical development and summary of research. Dialogues Clin Neurosci (2004) 0.86
Amyloid burden in the hippocampus and default mode network: relationships with gray matter volume and cognitive performance in mild stage Alzheimer disease. Medicine (Baltimore) (2015) 0.85
Computational models of the hippocampal region: implications for prediction of risk for Alzheimer's disease in non-demented elderly. Curr Alzheimer Res (2006) 0.83
Learning and generalization in healthy aging: implication for frontostriatal and hippocampal function. Cogn Behav Neurol (2012) 0.83
Differential effects of aging on spatial learning through exploratory navigation and map reading. Front Aging Neurosci (2012) 0.82
Gray-matter macrostructure in cognitively healthy older persons: associations with age and cognition. Brain Struct Funct (2013) 0.82
Predicting memory performance in normal ageing using different measures of hippocampal size. Neuroradiology (2005) 0.82
Hippocampal atrophy relates to fluid intelligence decline in the elderly. J Int Neuropsychol Soc (2010) 0.82
Structural Variation within the Amygdala and Ventromedial Prefrontal Cortex Predicts Memory for Impressions in Older Adults. Front Psychol (2012) 0.81
Structural imaging in early pre-states of dementia. Biochim Biophys Acta (2011) 0.81
Potential moderators of physical activity on brain health. J Aging Res (2012) 0.80
Tracking the Cognitive, Social, and Neuroanatomical Profile in Early Neurodegeneration: Type III Cockayne Syndrome. Front Aging Neurosci (2013) 0.79
The semantic variant of primary progressive aphasia: clinical and neuroimaging evidence in single subjects. PLoS One (2015) 0.78
Age-related changes in conventional and magnetization transfer MR imaging in elderly people: comparison with neurocognitive performance. Korean J Radiol (2004) 0.78
Age-related changes in the mesial temporal lobe: the parahippocampal white matter region. Neurobiol Aging (2011) 0.78
Aging impairs deliberation and behavioral flexibility in inter-temporal choice. Front Aging Neurosci (2015) 0.78
Prefrontal Lobe Brain Reserve Capacity with Resistance to Higher Global Amyloid Load and White Matter Hyperintensity Burden in Mild Stage Alzheimer's Disease. PLoS One (2016) 0.76
Relationship between Objectively Measured Transportation Behaviors and Health Characteristics in Older Adults. Int J Environ Res Public Health (2015) 0.76
Associations between Verbal Learning Slope and Neuroimaging Markers across the Cognitive Aging Spectrum. J Int Neuropsychol Soc (2015) 0.76
Preclinical Magnetic Resonance Imaging and Spectroscopy Studies of Memory, Aging, and Cognitive Decline. Front Aging Neurosci (2016) 0.75
The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry (1982) 10.83
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
A family intervention to delay nursing home placement of patients with Alzheimer disease. A randomized controlled trial. JAMA (1996) 4.80
Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci (1998) 4.76
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 4.31
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology (2007) 3.97
Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 3.77
The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience (2000) 3.40
Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging (2001) 3.25
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging (2005) 3.00
The Alzheimer's disease activities of daily living international scale (ADL-IS). Int Psychogeriatr (2001) 2.84
Mild cognitive impairment in the elderly: predictors of dementia. Neurology (1991) 2.83
Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging (2000) 2.80
Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. Neurology (2009) 2.76
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging (1997) 2.68
Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging (1997) 2.66
Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology (2008) 2.66
Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry (1987) 2.65
Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol (1998) 2.48
The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol (1993) 2.44
Hippocampal volume losses in minimally impaired elderly. Lancet (1995) 2.26
A comprehensive support program: effect on depression in spouse-caregivers of AD patients. Gerontologist (1995) 2.26
Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology (2005) 2.24
Global Deterioration Scale (GDS). Psychopharmacol Bull (1988) 2.14
Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann Neurol (1989) 2.08
Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet (1989) 2.02
Neuropsychological prediction of decline to dementia in nondemented elderly. J Geriatr Psychiatry Neurol (1999) 1.93
Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology (1991) 1.92
Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology (2004) 1.91
MRI of entorhinal cortex in mild Alzheimer's disease. Lancet (1999) 1.86
An intervention that delays institutionalization of Alzheimer's disease patients: treatment of spouse-caregivers. Gerontologist (1993) 1.72
Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol (1997) 1.67
CT diagnostic features of Alzheimer disease: importance of the choroidal/hippocampal fissure complex. AJNR Am J Neuroradiol (1990) 1.62
Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response. J Neurol Neurosurg Psychiatry (2000) 1.56
Brief Cognitive Rating Scale (BCRS). Psychopharmacol Bull (1988) 1.55
The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 1.53
The effects of mood changes and antidepressants on the cognitive capacity of elderly depressed patients. Int Psychogeriatr (1989) 1.50
Ocular lesions associated with HIV infection in India: a series of 100 consecutive patients evaluated at a referral center. Am J Ophthalmol (2000) 1.47
Age associated memory impairment. BMJ (1992) 1.41
Patterns of motor impairement in normal aging, mild cognitive decline, and early Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci (1997) 1.39
Volumetric analysis of the pre-frontal regions: findings in aging and schizophrenia. Psychiatry Res (2001) 1.38
Hippocampal atrophy in early Alzheimer's disease: anatomic specificity and validation. Psychiatr Q (1993) 1.33
Hypersensitivity to scopolamine in the elderly. Psychopharmacology (Berl) (1992) 1.33
Hippocampal formation size predicts declining memory performance in normal aging. Neurology (1996) 1.33
Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications. Arch Neurol (1992) 1.33
Atrophy rate in medial temporal lobe during progression of Alzheimer disease. Neurology (2004) 1.31
Hippocampal formation size in normal human aging: a correlate of delayed secondary memory performance. Learn Mem (1999) 1.31
A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology (1996) 1.24
Effects of naloxone in senile dementia: a double-blind trial. N Engl J Med (1983) 1.23
Cortisol differentially affects memory in young and elderly men. Behav Neurosci (2001) 1.19
Leukoencephalopathy in normal and pathologic aging: 2. MRI of brain lucencies. AJNR Am J Neuroradiol (1986) 1.18
In vivo structural studies of the hippocampus in normal aging and in incipient Alzheimer's disease. Ann N Y Acad Sci (1996) 1.17
Intracranial aneurysm on a persistent primitive trigeminal artery. Case report. J Neurosurg (1971) 1.15
Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease. J Cereb Blood Flow Metab (1983) 1.13
MRI volume of the amygdala: a reliable method allowing separation from the hippocampal formation. Psychiatry Res (1999) 1.13
Positron emission tomographic studies of aging and Alzheimer disease. AJNR Am J Neuroradiol (1983) 1.13
Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease. Brain Res (1998) 1.12
Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 1.12
Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study. J Nutr Health Aging (2009) 1.12
Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer's and other dementing processes. Eur Arch Psychiatry Clin Neurosci (1999) 1.12
An overview of current concepts of Alzheimer's disease. Am J Psychiatry (1982) 1.11
Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed. Psychopharmacology (Berl) (1990) 1.10
Novel white matter tract integrity metrics sensitive to Alzheimer disease progression. AJNR Am J Neuroradiol (2013) 1.10
Pure motor hemiplegia with occlusion of the extracranial carotid artery. J Neurol Sci (1973) 1.07
Prediction of longitudinal cognitive decline in normal elderly with subjective complaints using electrophysiological imaging. Neurobiol Aging (2005) 1.06
A two-year longitudinal study of cognitive function in normal aging and Alzheimer's disease. J Geriatr Psychiatry Neurol (1993) 1.05
Alzheimer's disease: longitudinal CT studies of ventricular change. AJR Am J Roentgenol (1989) 1.05
Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease. J Clin Endocrinol Metab (1997) 1.04